Paper314301
Low natural-killer-cell activity in familial melanoma patients and their relatives.
Hersey P and 3 others. Br J Cancer, 1979. Cited by 133 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Low natural-killer-cell activity in familial melanoma patients and their relatives. Papers, record 314301. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/314301
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Melanoma | Major topic |
| Adult | |
| Aged | |
| B-Lymphocytes | |
| Child | |
| Cytotoxicity, Immunologic | |
| Female | |
| Humans | |
| Immunity, Innate | |
| Male | |
| Middle Aged | |
| Mitosis | |
| Phytohemagglutinins | |
| Receptors, Antigen, B-Cell | |
| Rosette Formation |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 80,299 | Natural killer cells in the mouse: an alternative immune surveillance mechanism? | Contemp Top Immunobiol | 1978 | https://conductscience.org/library/papers/80299 | PubMed |
| 3 | 111,695 | Relationship of natural killer-cell activity to rhesus antigens in man. | Br J Cancer | 1979 | https://conductscience.org/library/papers/111695 | PubMed |
| 4 | 322,460 | Current concepts of the biology of human cutaneous malignant melanoma. | Adv Cancer Res | 1977 | https://conductscience.org/library/papers/322460 | PubMed |
| 5 | 705,260 | Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. | Scand J Immunol | 1978 | https://conductscience.org/library/papers/705260 | PubMed |
| 6 | 646,923 | Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients. | Br J Cancer | 1978 | https://conductscience.org/library/papers/646923 | PubMed |
| 7 | 4,739,655 | HL-A antigens in solid tumors. | Cancer Res | 1973 | https://conductscience.org/library/papers/4739655 | PubMed |
| 8 | 4,131,425 | Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. | J Natl Cancer Inst | 1974 | https://conductscience.org/library/papers/4131425 | PubMed |
| 9 | 4,600,315 | An improved rosetting assay for detection of human T lymphocytes. | J Immunol Methods | 1974 | https://conductscience.org/library/papers/4600315 | PubMed |
| 10 | 240,887 | Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C. | J Immunol | 1975 | https://conductscience.org/library/papers/240887 | PubMed |
| 11 | 1,150,347 | Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. | Int J Cancer | 1975 | https://conductscience.org/library/papers/1150347 | PubMed |
| 12 | 5,096,934 | Clinical characteristics of the genetic variety of cutaneous melanoma in man. | Cancer | 1971 | https://conductscience.org/library/papers/5096934 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,805,135 | Supercharged Natural Killer (sNK) Cells Inhibit Melanoma Tumor Progression and Restore Endogenous NK Cell Function in Humanized BLT Mice. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805135 | PubMed |
| 39,851,518 | Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs. | Cells | 2025 | https://conductscience.org/library/papers/39851518 | PubMed |
| 38,334,605 | Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy. | Cells | 2024 | https://conductscience.org/library/papers/38334605 | PubMed |
| 38,057,843 | The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/38057843 | PubMed |
| 37,275,901 | Immunometabolic reprogramming, another cancer hallmark. | Front Immunol | 2023 | https://conductscience.org/library/papers/37275901 | PubMed |
| 36,417,048 | The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer. | Int Urol Nephrol | 2023 | https://conductscience.org/library/papers/36417048 | PubMed |
| 36,032,129 | Innate lymphoid cells in early tumor development. | Front Immunol | 2022 | https://conductscience.org/library/papers/36032129 | PubMed |
| 35,967,421 | Natural killer cells: the next wave in cancer immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967421 | PubMed |
| 35,507,102 | Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/35507102 | PubMed |
| 35,326,467 | Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions. | Cells | 2022 | https://conductscience.org/library/papers/35326467 | PubMed |
| 34,878,657 | A functional variant in the immune signalling receptor NKG2D alters skin cancer risk. | Br J Dermatol | 2022 | https://conductscience.org/library/papers/34878657 | PubMed |
| 34,445,750 | Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445750 | PubMed |
| 34,201,655 | MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34201655 | PubMed |
| 33,802,954 | Targeting NK Cells to Enhance Melanoma Response to Immunotherapies. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33802954 | PubMed |
| 31,167,464 | Mast Cells and Natural Killer Cells-A Potentially Critical Interaction. | Viruses | 2019 | https://conductscience.org/library/papers/31167464 | PubMed |
| 30,761,123 | CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α. | Front Immunol | 2019 | https://conductscience.org/library/papers/30761123 | PubMed |
| 30,298,063 | Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression. | Front Immunol | 2018 | https://conductscience.org/library/papers/30298063 | PubMed |
| 30,282,672 | PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/30282672 | PubMed |
| 28,424,683 | Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients. | Front Immunol | 2017 | https://conductscience.org/library/papers/28424683 | PubMed |
| 28,360,428 | Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy. | Exp Mol Med | 2017 | https://conductscience.org/library/papers/28360428 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABO | 28 | PubTator's text mining | https://conductscience.org/library/genes/28 | NCBI Gene |
| HLA-A | 3,105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/314301
GET https://conductscience.org/api/papers/v1/314301/cited_by?page=2